Source author record

Ming Zhan

Ming Zhan appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

eess.SP Information Theory math.IT Molecular Networks Quantitative Methods

Catalog footprint

What is connected

2works

5topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2022arXiv

Short-Packet Interleaver against Impulse Interference in Practical Industrial Environments

The most common cause of transmission failure in Wireless High Performance (WirelessHP) target industry environments is impulse interference. As interleavers are commonly used to improve the reliability on the Orthogonal Frequency Division Multiplexing (OFDM) symbol level for long packet transmission, this paper considers the feasibility of applying short-packet bit interleaving to enhance the impulse/burst interference resisting capability on both OFDM symbol and frame level. Using the Universal Software Radio Peripherals (USRP) and PC hardware platform, the Packet Error Rate (PER) performance of interleaved coded short-packet transmission with Convolutional Codes (CC), Reed-Solomon codes (RS) and RS+CC concatenated codes are tested and analyzed. Applying the IEEE 1613 standard for impulse interference generation, extensive PER tests of CC(1=2) and RS(31; 21)+CC(1=2) concatenated codes are performed. With practical experiments, we prove the effectiveness of bit in terleaved coded short-packet transmission in real factory environments. We also investigate how PER performance depends on the interleavers, codes and impulse interference power and frequency.

preprint2020arXiv

Repurposing drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2

The Coronavirus Disease 2019 (COVID-19) pandemic has infected over 10 million people globally with a relatively high mortality rate. There are many therapeutics undergoing clinical trials, but there is no effective vaccine or therapy for treatment thus far. After affected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), molecular signaling of host cells plays critical roles during the life cycle of SARS-CoV-2. Thus, it is significant to identify the involved molecular signaling pathways within the host cells, and drugs targeting these molecular signaling pathways could be potentially effective for COVID-19 treatment. In this study, we aimed to identify these potential molecular signaling pathways, and repurpose existing drugs as a potentially effective treatment of COVID-19 to facilitate the therapeutic discovery, based on the transcriptional response of host cells. We first identified dysfunctional signaling pathways associated with the infection caused SARS-CoV-2 in human lung epithelial cells through analysis of the altered gene expression profiles. In addition to the signaling pathway analysis, the activated gene ontologies (GOs) and super gene ontologies were identified. Signaling pathways and GOs such as MAPK, JNK, STAT, ERK, JAK-STAT, IRF7-NFkB signaling, and MYD88/CXCR6 immune signaling were particularly identified. Based on the identified signaling pathways and GOs, a set of potentially effective drugs were repurposed by integrating the drug-target and reverse gene expression data resources. The dexamethasone was top-ranked in the prediction, which was the first reported drug to be able to significantly reduce the death rate of COVID-19 patients receiving respiratory support. The results can be helpful to understand the associated molecular signaling pathways within host cells, and facilitate the discovery of effective drugs for COVID-19 treatment.